13F Pro

SEC Form 4 reporting owner

Edwards Carladenise Armbrister

Edwards Carladenise Armbrister has filed 2 Form 4 transactions reported between January 6, 2026 and May 18, 2026, as Director of CLOVER HEALTH INVESTMENTS, CORP. /DE.

Name as filed: Edwards Carladenise Armbrister

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$230K
1 lines
Companies
1
with Form 4 filings
Latest transaction
May 18, 2026
transaction date

Roles and reported holdings

  • CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Jan 6, 2026 – May 18, 2026

    Director

    Held directly285,432 sh as of May 18, 2026 · Form 4

    24 months: $230K sold

Transaction history

All 2 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
May 18, 2026CLOVDirectorOpen-market saleCode S · direct67,160$230K@ $3.42Form 4
Jan 6, 2026CLOVDirectorGrant or awardCode A · direct79,365—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.